Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Vehicle-Controlled, Within-Subject, Comparison Study of the Safety, Tolerability, And Effectiveness of A-101 Topical Solution in Subjects With Seborrheic Keratosis
Conditions
Interventions
A-101 25%
A-101 32.5%
+2 more
Locations
1
United States
DermResearch, Inc.
Austin, Texas, United States
Start Date
October 22, 2013
Primary Completion Date
February 25, 2014
Completion Date
February 25, 2014
Last Updated
December 11, 2018
Lead Sponsor
Aclaris Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions